Suche
Mein Konto
New funding millions for research into chronic inflammatory diseases!
The PMI Cluster of Excellence at Kiel University will start a new funding round for precision medicine against chronic inflammation in 2026.
New funding millions for research into chronic inflammatory diseases!
The Cluster of Excellence “Precision Medicine for Chronic Inflammatory Diseases” (PMI) will be funded until the end of 2032 in a significant step towards the further development of medical research. This new funding commitment from the German Research Foundation (DFG) is in the context of a fourth funding phase that focuses on the clinical application of precision medicine. A total of almost 70 million euros is being requested to advance research and treatment of chronic inflammatory diseases that are affecting more and more people in industrialized nations, including Crohn's disease, psoriasis and rheumatism, reports Medical Faculty of the Universities of Kiel and Lübeck.
The PMI cluster is a joint initiative of the Christian Albrechts University of Kiel and the University of Lübeck, the University Hospital Schleswig-Holstein, the Borstel Research Center - Leibniz Lung Center, the Max Planck Institute for Evolutionary Biology Plön and the Muthesius Art University. The interdisciplinary collaboration of these institutions is crucial to develop innovative approaches for the early detection and treatment of chronic diseases. The cluster's priorities include early diagnosis, prediction of disease progression and individual assessment of treatment response.
Research with perspective
The aim of the Cluster of Excellence is to transfer interdisciplinary research approaches directly to health care, while taking into account the unmet needs of the sick. This is done by integrating innovative scientific findings into clinical practice to significantly improve patients' quality of life. The previous funding phase from 2019 to 2025, which was worth 52.2 million euros, already laid the foundation for this groundbreaking research.
The Cluster of Excellence follows its successful predecessor “Inflammation at Interfaces”, which was funded from 2007 to 2018. During this time, a solid basis for current research was created. The new cluster stands out with its focus on precision medicine, which enables individual and specific treatment of patients. This is particularly relevant given the increasing incidence of chronic inflammation in the population.
An alliance for the future
The commitment of these numerous institutions not only strengthens research into the treatment of inflammatory diseases, but also promotes the competitiveness of German universities. The federal and state excellence strategy (ExStra) supports various initiatives to strengthen top-level research in Germany. Within this framework, the interdisciplinary knowledge of the cluster members is used effectively to ensure the broadest and most in-depth research base possible University of Kiel turns out.
The efforts of the PMI cluster show how essential it is to integrate new medical findings and technologies into patient care in order to be able to meet the growing challenge posed by chronic inflammatory diseases. Future collaboration and expanded research opportunities promise to significantly improve healthcare systems and patient outcomes in the coming years. These developments underline the importance of research and innovation in modern medicine.